Medicine & Life Sciences
Heart Failure
100%
Atrial Fibrillation
45%
Heart
42%
Myocardial Infarction
34%
Atherosclerosis
32%
Cardiopulmonary Resuscitation
29%
Blood Pressure
29%
Mortality
27%
Hemodynamics
26%
Therapeutics
24%
Coronary Vessels
22%
Cardiovascular Diseases
22%
Heart-Assist Devices
21%
Heart Arrest
21%
Syncope
20%
Cardiac Arrhythmias
20%
Percutaneous Coronary Intervention
17%
Vasodilator Agents
17%
Pressure
17%
Dogs
17%
Hypertension
17%
Swine
16%
Cardiomyopathies
16%
Equipment and Supplies
16%
Survival
16%
Heart Rate
16%
Myocardium
16%
Stroke Volume
15%
Confidence Intervals
15%
Stroke
14%
Blood Vessels
14%
Heart Transplantation
14%
Cardiac Myocytes
14%
Arterial Pressure
13%
Perfusion
13%
Coronary Artery Disease
13%
Peripheral Arterial Disease
13%
Exercise
13%
Population
13%
Heart Ventricles
13%
Placebos
13%
Electrocardiography
13%
ST Elevation Myocardial Infarction
13%
Left Ventricular Dysfunction
12%
Implantable Defibrillators
12%
Stem Cells
12%
Pulmonary Hypertension
11%
Pulmonary Arterial Hypertension
11%
Registries
11%
Electric Impedance
11%
Heart Diseases
11%
Transplants
11%
Hospitalization
11%
Norepinephrine
10%
Ventricular Tachycardia
10%
Arteries
10%
Skeletal Muscle
10%
Ventricular Remodeling
10%
Incidence
10%
Ischemia
10%
Out-of-Hospital Cardiac Arrest
10%
Tachycardia
10%
Sudden Cardiac Death
10%
Left Ventricular Function
10%
Valsartan
10%
Left Ventricular Hypertrophy
10%
Brain Natriuretic Peptide
10%
Meta-Analysis
10%
Echocardiography
9%
Kidney
9%
Vascular Resistance
9%
Angiotensin-Converting Enzyme Inhibitors
9%
Myocardial Ischemia
9%
Ventricular Fibrillation
9%
Infarction
9%
Genes
9%
Vasovagal Syncope
9%
Clinical Trials
8%
Guidelines
8%
Lung
8%
Cell- and Tissue-Based Therapy
8%
Thrombosis
8%
Magnetic Resonance Spectroscopy
8%
Muscles
8%
Nitroprusside
8%
Health
7%
Coronary Disease
7%
Aspirin
7%
Regeneration
7%
Shock
7%
Pharmaceutical Preparations
7%
Safety
7%
Renin
7%
Adenosine Triphosphate
7%
Biomarkers
7%
Hydralazine
7%
Magnetic Resonance Imaging
7%
Acute Coronary Syndrome
7%
Elasticity
7%
Compliance
7%